WGSWW NASDAQ

GeneDx Holdings Corp., through its various operational units, specializes in delivering genomics-driven diagnostic and informational solutions. Central to its services is Centrellis, an advanced health intelligence platform powered by artificial intelligence. This platform effectively merges digital technologies with AI capabilities, enabling researchers to process and interpret extensive clinical and genomic datasets to generate thorough health insights. The company provides genetic testing for diagnosis, a range of screening programs, and pertinent information, with a primary focus on pediatric conditions, uncommon diseases affecting both adults and children, and screening for inherited cancers. GeneDx Holdings Corp. was established in 2017 and its main offices are located in Stamford, Connecticut.